Cargando…
Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection
BACKGROUND: Echinococcus multilocularis causes alveolar echinococcosis (AE), a rising zoonotic disease in the northern hemisphere. Treatment of this fatal disease is limited to chemotherapy using benzimidazoles and surgical intervention, with frequent disease recurrence in cases without radical surg...
Autores principales: | Weingartner, Michael, Stücheli, Simon, Jebbawi, Fadi, Gottstein, Bruno, Beldi, Guido, Lundström-Stadelmann, Britta, Wang, Junhua, Odermatt, Alex |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794265/ https://www.ncbi.nlm.nih.gov/pubmed/35030165 http://dx.doi.org/10.1371/journal.pntd.0009192 |
Ejemplares similares
-
Impact on Bile Acid Concentrations by Alveolar Echinococcosis and Treatment with Albendazole in Mice
por: Gómez, Cristina, et al.
Publicado: (2021) -
Foxp3(+) T Regulatory Cells as a Potential Target for Immunotherapy against Primary Infection with Echinococcus multilocularis Eggs
por: Wang, Junhua, et al.
Publicado: (2018) -
Drug repurposing applied: Activity of the anti-malarial mefloquine against Echinococcus multilocularis
por: Lundström-Stadelmann, Britta, et al.
Publicado: (2020) -
In vitro metabolomic footprint of the Echinococcus multilocularis metacestode
por: Ritler, Dominic, et al.
Publicado: (2019) -
Dual inhibition of the Echinococcus multilocularis energy metabolism
por: Chaudhry, Sheena, et al.
Publicado: (2022)